MEGAN ALEXANDER: Open Payments
NPI 1952093635 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 39 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $212 · 2025 $773
Food & beverage: $760Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $180 |
| Lilly USA, LLC | 10 | $159 |
| Gilead Sciences, Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Exact Sciences Corporation | 2 | $27 |
| Antares Pharma, Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $23 |
Products named: MOUNJARO, FARXIGA, AIRSUPRA, JARDIANCE, GIVLAARI, TZIELD, QULIPTA, Wegovy.
Industry payments across KY — which companies pay providers there.
